Skip to content

Inspire Corporate Bond ETF

IBDNYSE ArcaInspireD

$23.230.00 (0.00%)

At close: Nov 2, 2026, 4:00 PM ET

Intraday session: flat, 79 prints from 23.23 to 23.23. Range 23.23 to 23.29. Use the arrow keys to read each point.23.2523.2623.2723.2823.2910 AM12 PM2 PM4 PM
Expense ratio
0.41%
Fund size
$483M
1Y total return
+1.1%
Yield · Last 12 months
4.41%
Holdings
252
Avg volume · 30D
97.7K sh
52W range
low $22.50high $24.78
Launched
Filings
SEC EDGAR

The ETF.net IBD Grade

D

Score 37 out of 100

Rank
42 of 49
Six-pillar profile for IBD. Scores out of 100: Cost 17, Risk 55, Mission 49, Tradability 41, Holdings 35, Durability 48. Strongest: Risk (55). Weakest: Cost (17). Leans toward Risk and Mission.

Score 37 of 100 falls in the D band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    F17 out of 100
    Rank 41 of 49
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    C49 out of 100
    Rank 41 of 45
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    B55 out of 100
    Rank 16 of 49
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    C41 out of 100
    Rank 32 of 49
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    D35 out of 100
    Rank 41 of 49
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    C48 out of 100
    Rank 28 of 49

Our read on IBD

ETF.net Research

In short

DThe first bond ETF ever built on biblical-values screens. IBD holds intermediate-term investment grade US corporate debt from companies that clear Inspire's rules-based Impact Score, and pays monthly.

Stated mandate

The fund seeks to track the Inspire Corporate Bond Impact Index before fees and expenses. It generally invests at least 80% of assets in the index's component securities.

Why people hold it

  • The original of its kind: launched in 2017 as the first faith-based bond ETF, so it has years of live operating history behind the screen, not a back-test.yahoo.com
  • The screen is rules-based, not a vibe. Inspire's Impact Score rates companies from -100 to +100 and docks points for exclusionary violations, so inclusion logic is published.website-files.com
  • Plain-vanilla plumbing under the values layer: investment grade corporate bonds, intermediate maturities, at least 80% in index components, with income paid monthly.website-files.com
  • Rare scale for a conviction fund: assets in the hundreds of millions and moderate day-to-day trading, where most values-screened bond funds stay tiny.

Worth knowing

  • Conviction costs. At 0.41% a year, IBD runs above the typical investment grade corporate bond ETF, and well above index staples like VCIT (0.03%) and USIG (0.04%).
  • Screening out whole industries shrinks the bond universe, so sector and issuer mix can look different from a broad corporate bond benchmark.website-files.com
  • Among dozens of investment grade corporate bond ETFs, it sits in the lower tier of the group, mostly on fees and trading friction rather than what it owns.

IBD Performance

Launched Jul 10, 2017

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.
IBD$10,114
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,199
Oct 31, 2025 to Oct 30, 2026. IBD $10,114. SPY $11,199. Use the arrow keys to read each point.$10,000$11,000Oct 2025Apr 2026Oct 2026

Oct 31, 2025 – Oct 30, 2026

Returns run to the Oct 30, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for IBD. Periods over one year show the average yearly return.
PeriodIBD
Year to date−0.6%
1 month+1.4%
3 months−0.4%
1 year+1.1%
3 yearsper year+5.7%
5 yearsper year+1.3%
10 yearsFund is under 10 years oldper yearNo data

With distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for IBD
YearReturn barIBD
2026 YTD−0.6%
2025+7.7%
2024+3.6%
2023+6.0%
2022−8.9%
2021−1.9%
2020+5.1%

IBD in the news

IBD Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 30, 2026.
4.41%Last 12 months
Payout per share
$1.03Last 12 months
Upcoming payment
$0.10 per share
Pays on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Monthly

Distribution history

2023–2026

One bar per payment. 46 payments from 2023 to 2026 YTD. Jan 27, 2023 $0.04; Feb 24, 2023 $0.05; Mar 27, 2023 $0.04; Apr 27, 2023 $0.07; May 26, 2023 $0.07; Jun 23, 2023 $0.06; Jul 27, 2023 $0.07; Aug 25, 2023 $0.06; Sep 22, 2023 $0.06; Oct 27, 2023 $0.09; Nov 21, 2023 $0.06; Dec 14, 2023 $0.11; Jan 26, 2024 $0.06; Feb 23, 2024 $0.07; Mar 27, 2024 $0.08; Apr 26, 2024 $0.07; May 24, 2024 $0.08; Jun 25, 2024 $0.08; Jul 26, 2024 $0.10; Aug 26, 2024 $0.07; Sep 25, 2024 $0.09; Oct 28, 2024 $0.08; Nov 22, 2024 $0.07; Dec 16, 2024 $0.12; Jan 27, 2025 $0.06; Feb 24, 2025 $0.07; Mar 27, 2025 $0.09; Apr 25, 2025 $0.08; May 23, 2025 $0.08; Jun 26, 2025 $0.10; Jul 25, 2025 $0.08; Aug 26, 2025 $0.08; Sep 26, 2025 $0.09; Oct 28, 2025 $0.08; Nov 21, 2025 $0.07; Dec 17, 2025 $0.12; Jan 27, 2026 $0.06; Feb 24, 2026 $0.08; Mar 27, 2026 $0.09; Apr 24, 2026 $0.08; May 22, 2026 $0.08; Jun 26, 2026 $0.10; Jul 24, 2026 $0.08; Aug 26, 2026 $0.09; Sep 25, 2026 $0.08; Oct 28, 2026 $0.10. Use the arrow keys to read each point.2023202420252026YTD
Ex-datePay dateAmount per share
Oct 28, 2026Pays Nov 2, 2026$0.10
Sep 25, 2026Oct 1, 2026$0.08
Aug 26, 2026Aug 31, 2026$0.09
Jul 24, 2026Jul 29, 2026$0.08
Jun 26, 2026Jul 1, 2026$0.10
May 22, 2026May 27, 2026$0.08
Apr 24, 2026Apr 29, 2026$0.08
Mar 27, 2026Apr 1, 2026$0.09
Feb 24, 2026Mar 2, 2026$0.08
Jan 27, 2026Feb 2, 2026$0.06
Dec 17, 2025Dec 24, 2025$0.12
Nov 21, 2025Nov 26, 2025$0.07

See all 111 payments⁠

$10,000 in IBD 5 years ago paid $1,585 in dividends.⁠

IBD Risk

How much the fund’s monthly returns vary, scaled to a year.
4.2%
Annualised · 36 months to Oct 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.28
vs 3-month T-bills · to Oct 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−13.7%
Trough Oct 2022
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.66
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FMP measures it over up to five years of monthly returns.

IBD Cost

Overpaying vs SPBO, tied cheapest in Investment Grade Corporate

$7,643

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • IBD 0.41%

    $8,281

  • SPBO 0.03% Tied cheapest

    $638

$10,000
30 years

Cost over time

  • IBD 0.41%
  • SPBO 0.03%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$2K$4K$6K$8K$10K051015202530IBD $8,281SPBO $638

Year by year

YearIBDSPBOOverpaying
10$741$55$686
20$2,860$216$2,644
30$8,281$638$7,643

Other funds in Investment Grade Corporate